| Darunavir |
EU/1/06/380/003 |
PREZISTA, Film coated tablet, 400, mg, Pack: 60 |
Janssen-Cilag International N.V., Белгия |
Janssen-Cilag SpA, Italy |
685.54 |
137.11 |
822.65 |
4% |
10 |
695.54 |
139.11 |
834.65 |
16% |
25 |
720.54 |
144.11 |
864.65 |
|
НСР-5751/26.02.2015. |
12.03.2015 |
12.03.2015 |
Неактивен |
3628 |
| Darunavir |
EU/1/06/380/002 |
PREZISTA, Film coated tablet, 600, mg, Pack: 60 |
Janssen-Cilag International N.V., Белгия |
Janssen –Cilag SpA, Италия |
1023.62 |
204.72 |
1228.34 |
4% |
10 |
1033.62 |
206.72 |
1240.34 |
16% |
25 |
1058.62 |
211.72 |
1270.34 |
|
НСР-4998/05.11.2014; НСР-9721/07.07.2016 |
02.08.2016 |
02.08.2016 |
Активен |
3333 |
| Darunavir |
EU/1/06/380/002 |
PREZISTA, Film coated tablet, 600, mg, Pack: 60 |
Janssen-Cilag International N.V., Белгия |
Janssen –Cilag SpA, Италия |
1025.11 |
205.02 |
1230.13 |
4% |
10 |
1035.11 |
207.02 |
1242.13 |
16% |
25 |
1060.11 |
212.02 |
1272.13 |
|
НСР-4998/05.11.2014 |
19.11.2014 |
19.11.2014 |
Неактивен |
3333 |
| Darunavir |
EU/1/06/380/003 |
PREZISTA, Film coated tablet, 400, mg, Pack: 60 |
Janssen-Cilag International N.V., Белгия |
Janssen-Cilag SpA, Italy |
702.36 |
140.47 |
842.83 |
4% |
10 |
712.36 |
142.47 |
854.83 |
16% |
25 |
737.36 |
147.47 |
884.83 |
|
НСР-3989/30.06.2014 |
15.07.2014 |
15.07.2014 |
Неактивен |
3628 |
| Darunavir |
EU/1/06/380/002 |
PREZISTA, Film coated tablet, 600, mg, Pack: 60 |
Janssen-Cilag International N.V., Белгия |
Janssen –Cilag SpA, Италия |
1052.35 |
210.47 |
1262.82 |
4% |
10 |
1062.35 |
212.47 |
1274.82 |
16% |
25 |
1087.35 |
217.47 |
1304.82 |
|
НСР-1731/21.11.2013 |
20.03.2014 |
20.03.2014 |
Неактивен |
3333 |
| Darunavir |
EU/1/06/380/003 |
PREZISTA, Film coated tablet, 400, mg, Pack: 60 |
Janssen-Cilag International N.V., Белгия |
Janssen-Cilag SpA, Italy |
722.09 |
144.42 |
866.51 |
4% |
10 |
732.09 |
146.42 |
878.51 |
16% |
25 |
757.09 |
151.42 |
908.51 |
|
НСР-1618/01.11.2013 |
25.11.2013 |
25.11.2013 |
Неактивен |
3628 |
| Darunavir |
EU/1/06/380/002 |
PREZISTA, Film coated tablet, 600, mg, Pack: 60 |
Janssen-Cilag International N.V., Белгия |
Janssen –Cilag SpA, Италия |
1113.79 |
222.76 |
1336.55 |
4% |
10 |
1123.79 |
224.76 |
1348.55 |
16% |
25 |
1148.79 |
229.76 |
1378.55 |
|
КЦРР-1165/08.08.2012 |
25.09.2012 |
25.09.2012 |
Неактивен |
3333 |
| Darunavir |
EU/1/06/380/002 |
PREZISTA, Film coated tablet, 600, mg, Pack: 60 |
Janssen-Cilag International N.V., Белгия |
Janssen –Cilag SpA, Италия |
1254.27 |
250.85 |
1505.12 |
4% |
10 |
1264.27 |
252.85 |
1517.12 |
16% |
25 |
1289.27 |
257.85 |
1547.12 |
|
КЦ-1364/12.02.2010 |
03.03.2010 |
03.03.2010 |
Неактивен |
3333 |
| Darunavir |
EU/1/06/380/003 |
PREZISTA, Film coated tablet, 400, mg, Pack: 60 |
Janssen-Cilag International N.V., Белгия |
Janssen-Cilag SpA, Italy |
835.53 |
167.11 |
1002.64 |
4% |
10 |
845.53 |
169.11 |
1014.64 |
16% |
25 |
870.53 |
174.11 |
1044.64 |
корек КЦ-1356/04.02.2010 |
КЦ-1288/19.01.2010 |
03.02.2010 |
03.02.2010 |
Неактивен |
3628 |
| Darunavir |
EU/1/06/380/007 |
PREZISTA, Film coated tablet, 800, mg, Pack: 30 |
Janssen-Cilag International N.V., Белгия |
Janssen – Cilag SpA, Италия |
685.79 |
137.16 |
822.95 |
4% |
10 |
695.79 |
139.16 |
834.95 |
16% |
25 |
720.79 |
144.16 |
864.95 |
|
НСР-8441/07.03.2016 |
22.03.2016 |
22.03.2016 |
Активен |
4025 |
| Darunavir |
EU/1/06/380/007 |
PREZISTA, Film coated tablet, 800, mg, Pack: 30 |
Janssen-Cilag International N.V., Белгия |
Janssen – Cilag SpA, Италия |
694.16 |
138.83 |
832.99 |
4% |
10 |
704.16 |
140.83 |
844.99 |
16% |
25 |
729.16 |
145.83 |
874.99 |
|
НСР-6572/24.06.2015 |
10.07.2015 |
10.07.2015 |
Неактивен |
4025 |
| Darunavir |
0914/22.10.2007 |
PREZISTA, Film coated tablet, 800, mg, Pack: 30 |
Woerwag Pharma GmbH & Co.KG, Германия |
Artesan Pharma GmbH&Co.KG, Germany: Chanelle Medical, Ireland |
7.71 |
1.54 |
9.25 |
7% |
0.54 |
8.25 |
1.65 |
9.9 |
20% |
1.54 |
9.79 |
1.96 |
11.75 |
промяна на обстоятелства решение КЦ-3084/04.11.2011 |
КЦ-2987/14.10.2011 |
01.11.2011 |
01.11.2011 |
Неактивен |
4025 |
| Norethisterone |
9900329 |
PRIMOLUT-NOR-5, Tablet, 5, mg, Pack: 20 |
Bayer Pharma AG, Германия |
Bayer Pharma AG; Bayer Weimar GmbH & Co KG, Германия |
2.35 |
0.47 |
2.82 |
7% |
0.16 |
2.51 |
0.5 |
3.01 |
20% |
0.47 |
2.98 |
0.6 |
3.58 |
промяна в обстоятелствата HCP-5721/26.02.2015; корекционно решение НСР-8646/31.05.2016; цената е вписана в регистърна на пределните цени с решение НСР-8647/31.03.2016. (в сила от 02.05.2016) |
КЦ-353/19.12.2008 |
22.01.2009 |
22.01.2009 |
Заличен |
363 |
| Perindopril, Indapamide |
II-14879/ 15.09.2011 |
Prindex plus, Tablet, 4 mg/ 1,25 mg, mg, Pack: 30 |
Glenmark Pharmaceuticals s.r.o., Чешка република |
Glenmark Pharmaceuticals s.r.o., Belohorska 39/260, 169 00 Praha 6, Fibichova 143 566 17 Vysoke Myto, Чехия |
6.57 |
1.31 |
7.88 |
7% |
0.46 |
7.03 |
1.41 |
8.44 |
20% |
1.31 |
8.34 |
1.67 |
10.01 |
Цената се заличава с решение НСР-2115/11.12.2013 |
КЦРР-1720/28.11.2012 |
13.12.2012 |
13.12.2012 |
Заличен |
1467 |
| Perindopril |
20140021 |
Prinopril, Tablet, 8, mg, Pack: 30 |
Унифарм АД, България |
Унифарм АД, България |
6.98 |
1.4 |
8.38 |
7% |
0.49 |
7.47 |
1.49 |
8.96 |
20% |
1.4 |
8.87 |
1.77 |
10.64 |
|
НСР-3032/21.03.2014 |
08.04.2014 |
08.04.2014 |
Активен |
2616 |
| Perindopril |
20140022 |
Prinopril, Tablet, 4, mg, Pack: 30 |
Унифарм АД, България |
Унифарм АД, България |
3.49 |
0.7 |
4.19 |
7% |
0.24 |
3.73 |
0.75 |
4.48 |
20% |
0.7 |
4.43 |
0.89 |
5.32 |
|
НСР-3032/21.03.2014 |
08.04.2014 |
08.04.2014 |
Активен |
2617 |
| Measles, mumps and rubella vaccine (live) |
II-3035 / 18.09.2008 г. |
Priorix, Powder and solvent for suspension for injection, 1 dose 0.5 ml, -, Pack: 1 vial with powder + 1 pre-filled syr. 0,5 ml solv + 2 separate needles |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals, rue de l'Institut 89, 1330 Rixensart, Belgium |
14.96 |
2.99 |
17.95 |
6% |
0.9 |
15.86 |
3.17 |
19.03 |
18% |
2.69 |
18.55 |
3.71 |
22.26 |
|
КЦРР-718/07.06.2012 |
26.06.2012 |
26.06.2012 |
Активен |
1234 |
| Measles, mumps and rubella vaccine (live) |
9800351 |
Priorix, Powder and solvent for suspension for injection, 1 dose 0.5 ml, -, Pack: 1 vial with powder + 1 ampoule with solvent |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals, rue de l’Institut 89, 1330 Rixensart, Белгия |
14.67 |
2.93 |
17.6 |
6% |
0.88 |
15.55 |
3.11 |
18.66 |
18% |
2.64 |
18.19 |
3.64 |
21.83 |
|
НСР-7216/15.10.2015. |
30.10.2015 |
30.10.2015 |
Активен |
4084 |
| Measles, mumps and rubella vaccine (live) |
9800351 |
Priorix, Powder and solvent for suspension for injection, 1 dose 0.5 ml, -, Pack: 100 vial with powder + 100 ampoule with solvent |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals, rue de l’Institut 89, 1330 Rixensart, Белгия |
1550 |
310 |
1860 |
4% |
10 |
1560 |
312 |
1872 |
16% |
25 |
1585 |
317 |
1902 |
|
НСР-8093/17.02.2016. (допуска предварително изпълнение) |
17.02.2016 |
17.02.2016 |
Активен |
4184 |
| Measles, mumps and rubella vaccine (live) |
II-3035/18.09.2008 |
Priorix, Powder and solvent for suspension for injection, Live attenuated measles virus (Schwarz strain) 1; Live attenuated mumps virus (RIT 4385 strain) 1; Live attenuated rubella virus (Wistar RA 27/3 strain) 1, -, Pack: 1 |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals, Belgium |
14.67 |
2.93 |
17.6 |
6% |
0.88 |
15.55 |
3.11 |
18.66 |
18% |
2.64 |
18.19 |
3.64 |
21.83 |
цената се заличава КЦРР-1642/15.11.2012 |
КЦ-1274/29.12.2009 |
17.01.2010 |
17.01.2010 |
Заличен |
855 |
| Measles, mumps and rubella vaccine (live) |
II-3035 / 18.09.2008 г. |
Priorix, Powder and solvent for solution for injection, Live attenuated measles virus (Schwarz strain) 1; Live attenuated mumps virus (RIT 4385 strain) 1; Live attenuated rubella virus (Wistar RA 27/3 strain) 1, mg, Pack: 1 |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals, rue de l'Institut 89, 1330 Rixensart, Belgium |
19.32 |
3.86 |
23.18 |
8% |
1.55 |
20.87 |
4.17 |
25.04 |
20% |
3.86 |
24.73 |
4.95 |
29.68 |
корекционна КЦ-1087/13.08.2009 |
КЦ-704/09.03.2009 |
24.03.2009 |
24.03.2009 |
Неактивен |
1234 |
| Immunoglobulins, normal human |
EU/1/08/446/002 |
Privigen, Solution for infusion, 100 mg/ml - 100 ml, mg, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH, Германия |
759.94 |
151.99 |
911.93 |
4% |
10 |
769.94 |
153.99 |
923.93 |
16% |
25 |
794.94 |
158.99 |
953.93 |
|
НСР-7189/09.10.2015. |
24.10.2015 |
24.10.2015 |
Активен |
2008 |
| Immunoglobulins, normal human |
EU/1/08/446/004 |
Privigen, Solution for infusion, 100 mg/ml - 25 ml, mg, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH Германия |
194.45 |
38.89 |
233.34 |
4% |
7.78 |
202.23 |
40.45 |
242.68 |
16% |
25 |
227.23 |
45.45 |
272.68 |
|
НСР-7187/09.10.2015. |
24.10.2015 |
24.10.2015 |
Активен |
2006 |
| Immunoglobulins, normal human |
EU/1/08/446/001 |
Privigen, Solution for infusion, 100 mg/ml - 50 ml, mg, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH, Германия |
379.63 |
75.93 |
455.56 |
4% |
10 |
389.63 |
77.93 |
467.56 |
16% |
25 |
414.63 |
82.93 |
497.56 |
|
НСР-7188/09.10.2015. |
24.10.2015 |
24.10.2015 |
Активен |
2007 |
| Immunoglobulins, normal human |
EU/1/08/446/002 |
Privigen, Solution for infusion, 100 mg/ml - 100 ml, mg, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH, Германия |
790.55 |
158.11 |
948.66 |
4% |
10 |
800.55 |
160.11 |
960.66 |
16% |
25 |
825.55 |
165.11 |
990.66 |
|
НСР-155/18.06.2013 |
15.08.2013 |
15.08.2013 |
Неактивен |
2008 |